Hepatitis C Prevalence in Men Who Have Sex With Men
CRIBADO DE VIRUS DE LA HEPATITIS C en Hombres Que Tienen Sexo Con Hombres (HSH) Sitges
1 other identifier
observational
454
1 country
1
Brief Summary
This is an observational study aimed at determining the prevalence of hepatitis C in a specific population: men who have sex with men.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 11, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 11, 2022
CompletedFirst Submitted
Initial submission to the registry
September 16, 2024
CompletedFirst Posted
Study publicly available on registry
September 20, 2024
CompletedFebruary 12, 2025
September 1, 2024
2 days
September 16, 2024
February 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with Hepatitis C screening positive
A positive result will be defined as a positive outcome in both the serological test and the viral load test
Baseline
Study Arms (1)
Men who have sex with men
Interventions
Eligibility Criteria
Population attending the \"International Bears Sitges Week\" festival in September 2022 in Sitges, Barcelona.
You may qualify if:
- Having sex with men
You may not qualify if:
- Refusal to participate in the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Consorci Sanitari Alt Penedès Garraf
Vilafranca del Penedès, Barcelona, 08720, Spain
Related Publications (1)
Albertos S, Majo FX, Esteban R, Colom J, Buti M. A large-scale screening of hepatitis C among men who have sex with men in the community using saliva point-of-care testing. Front Public Health. 2024 Dec 9;12:1478195. doi: 10.3389/fpubh.2024.1478195. eCollection 2024.
PMID: 39717035RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sonia Albertos, MD
CSAPG
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2024
First Posted
September 20, 2024
Study Start
September 9, 2022
Primary Completion
September 11, 2022
Study Completion
September 11, 2022
Last Updated
February 12, 2025
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- After publication of main results of the study.
- Access Criteria
- IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.
IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).